Medication List

Created by

Michael Lee

Specialty

Psychiatrist

Last edited

10/20/2026

Uses

0 times

Tags

Psychiatrist

About this template

A reusable medication-management template for documenting each medication’s names, class, indication, dosing, duration, side effects, benefits, dependence, and treatment response. It is suitable for organized medication tracking, including psychiatric care.

Preview template

Lithobid/lithium carbonate (Mood stabilizer): Bipolar I disorder
- Dose: 450 mg PO BID
- Duration: Started 12/03/2021 (3 years)
- Side effects: Mild fine hand tremor, polyuria; stabilizes mood; no dependence
- Response: Good efficacy; prevents manic episodes
Lamictal/lamotrigine (Anticonvulsant/Mood stabilizer): Bipolar depression prophylaxis
- Dose: 200 mg PO QAM
- Duration: Started 15/06/2022 (2 years)
- Side effects: None reported; no rash; improves depressive baseline; no dependence
- Response: Effective in reducing depressive relapses
Seroquel/quetiapine (Atypical antipsychotic): Acute agitation and insomnia in Bipolar I
- Dose: 100 mg PO QHS
- Duration: Started 04/11/2023 (6 months)
- Side effects: Morning grogginess, +3 kg weight gain; improves sleep architecture; no dependence
- Response: Effective for sleep maintenance and mood stabilization
Klonopin/clonazepam (Benzodiazepine): Generalized anxiety disorder (GAD), acute panic
- Dose: 0.5 mg PO BID PRN
- Duration: Started 20/01/2020 (4 years)
- Side effects: Mild sedation; rapid anxiolysis; physiological dependence present, tapering discussed
- Response: High efficacy for breakthrough panic attacks
Inderal/propranolol (Beta-blocker): Lithium-induced tremor and somatic anxiety
- Dose: 20 mg PO BID
- Duration: Started 10/04/2021 (3 years)
- Side effects: None, normotensive; reduces tremor and palpitations; no dependence
- Response: Moderate reduction in hand tremor
Synthroid/levothyroxine (Thyroid hormone): Lithium-induced hypothyroidism
- Dose: 75 mcg PO QAM
- Duration: Started 01/09/2022 (1.5 years)
- Side effects: None; resolves lethargy; no dependence
- Response: Euthyroid on recent labs (TSH 2.1 mIU/L)
Glucophage/metformin (Biguanide): Antipsychotic-induced metabolic syndrome
- Dose: 500 mg PO BID
- Duration: Started 12/01/2024 (4 months)
- Side effects: Transient GI upset; stabilizes weight; no dependence
- Response: HbA1c stable at 5.8%
Lipitor/atorvastatin (Statin): Dyslipidemia
- Dose: 20 mg PO QHS
- Duration: Started 12/01/2024 (4 months)
- Side effects: No myalgias; lowers LDL; no dependence
- Response: Good lipid control
Zestril/lisinopril (ACE inhibitor): Essential hypertension
- Dose: 10 mg PO QAM
- Duration: Started 05/05/2019 (5 years)
- Side effects: None, no cough; BP control; no dependence
- Response: BP well-controlled (122/78 mmHg)
Prilosec/omeprazole (Proton pump inhibitor): GERD
- Dose: 20 mg PO QAM
- Duration: Started 18/08/2021 (2.5 years)
- Side effects: None; resolves heartburn; rebound reflux if missed
- Response: Complete resolution of dyspepsia
Catapres/clonidine (Alpha-2 agonist): ADHD, combined type / sleep onset
- Dose: 0.1 mg PO QHS
- Duration: Started 22/02/2024 (3 months)
- Side effects: Dry mouth; aids sleep initiation and impulse control; no dependence
- Response: Mild improvement in evening restlessness
Cogentin/benztropine (Anticholinergic): Extrapyramidal symptoms (EPS) prophylaxis
- Dose: 1 mg PO QHS PRN
- Duration: Started 04/11/2023 (6 months, used intermittently)
- Side effects: Mild dry mouth, constipation; resolves jaw stiffness; no dependence
- Response: Effective when mild akathisia/dystonia occurs

How to use this template

This template can be used to assist with various tasks in the medical field. You can use it to generate notes, manage patient information, or assist with diagnosis and the Assessment and Plan. To use this template, simply click the “Use Template” button above. If you have any questions or need assistance, feel free to reach out to the support team or refer to the description and example output provided above.